Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

35.78
Delayed Data
As of 3:59pm ET
 +0.90 / +2.58%
Today’s Change
28.48
Today|||52-Week Range
46.81
-1.38%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close34.88
Today’s open34.82
Day’s range34.67 - 35.90
Volume194,125
Average volume (3 months)403,651
Market cap$1.5B
Data as of 3:59pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+40.06%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio62.8
Price/Sales10.05
Price/Book6.99

Competitors

 Today’s
change
Today’s
% change
MYOKMyoKardia Inc+1.05+1.98%
ARRYArray Biopharma Inc+0.26+2.02%
LXRXLexicon Pharmaceutic...+0.20+1.95%
EBSEmergent BioSolution...+1.59+3.21%
Data as of 4:02pm ET, 01/19/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$0.12
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts